-
801
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
Published 2020-05-01“…Abstract Small molecular PD‐1 inhibitors are lacking in current immuno‐oncology clinic. PD‐1/PD‐L1 antibody inhibitors currently approved for clinical usage block interaction between PD‐L1 and PD‐1 to enhance cytotoxicity of CD8+ cytotoxic T lymphocyte (CTL). …”
Get full text
Article -
802
Plasma polymeric immunoglobulin receptor exacerbates lung injury in Klebsiella pneumoniae-induced pneumosepsis
Published 2025-06-01“…Intravenous administrations of recombinant pIgR (r_pIgR) increased the mortality in mouse models of Klebsiella pneumoniae (KP)-induced pneumosepsis (KPS) and polymicrobial sepsis. r_pIgR also increased the injury score, caspase-11 and GSDMD-NT in the lungs of KPS mice. pIgR-neutralizing antibody (pIgR_Ab) exhibited opposite effects on animal survival in both sepsis models and on the injury score, caspase-11 and GSDMD-NT. …”
Get full text
Article -
803
MODERN OPPORTUNITIES IN UVEITIS TREATMENT
Published 2017-07-01“…So the search continues to develop new therapies for use in uveitis that aim to suppress inflammatory activit y, prevent accumulation of damage, and preserve visual function for patients with the minimum possible side effects.…”
Get full text
Article -
804
Prognostic significance and immune infiltration analysis of HMGA2 in endometrial cancer
Published 2025-07-01“…The combination of HMGA2 inhibitors and targeted macrophage immunotherapy (CD47 monoclonal antibody) had the better tumor suppression effect. …”
Get full text
Article -
805
Current advances in the role of classical non‐homologous end joining in hematologic malignancies
Published 2025-06-01“…Such DSBs, which require NHEJ for resolution, can arise from intrinsic and extrinsic DNA‐damaging factors or emerge naturally during essential biological processes like V(D)J recombination and antibody class switch recombination. Main Body Failure to properly repair DSBs may lead to genomic instability, disruption of cellular functions, and immunodeficiency, thereby promoting the development of hematologic malignancies. …”
Get full text
Article -
806
Pervasiveness of urinary tract infection in diabetic patients and their causative organisms with antibiotic sensitivity pattern
Published 2020-01-01“…DM also hampers immunologic functions such as phagocytosis, decrease in antibody production, failure of T cells and B cells to fight against pathogens which ameliorate bacterial growth. …”
Get full text
Article -
807
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
Published 2018-01-01“…T cells expressing CAR have specific activation and cytotoxic effects against cancer cells containing the target antigen. …”
Get full text
Article -
808
CXCL13 suppresses liver regeneration through the negative regulation of HGF signaling
Published 2025-05-01“…Importantly, treatment with CXCL13-neutralizing antibody effectively improved liver regeneration in mice PHx model. …”
Get full text
Article -
809
Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient
Published 2017-01-01“…Four other cases of AIN reported along with inhibition of the vascular endothelial growth factor (VEGF) by either TKI (sunitinib and sorafenib) or antibodies (bevacizumab) suggest a possible class effect. …”
Get full text
Article -
810
Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques
Published 2025-08-01“…To improve the safety profile of these molecules, it is imperative to understand the consequences of anti-Aβ antibody treatment on immune cell function. Here, we investigated the effects of long-term chronic anti-Aβ treatment on amyloid plaque pathology and microglial response in the APP-SAA triple knock-in mouse model with an intervention paradigm early during amyloidogenesis. …”
Get full text
Article -
811
Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves Trogocytosis
Published 2024-12-01“…Reduced CD8<sup>+</sup> T cell TIGIT expression with TIGIT blockade involved trogocytosis by circulating monocytes, suggesting that an effector monocyte population and intact fragment crystallizable (Fc) functions are required for mAb-based TIGIT blockade to effectively enhance HIV-specific CD8<sup>+</sup> T cell responses.…”
Get full text
Article -
812
Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors
Published 2025-01-01“…The correlation between PD‐L1 expression and ICI effectiveness is uncertain, leaving the role of PD‐L1 as a predictive marker for ICI efficacy unclear. …”
Get full text
Article -
813
Association of rituximab use with adverse events in adults with lymphoma or autoimmune disease: a single center experience
Published 2025-04-01“…ObjectiveRituximab (RTX) is a chimeric human/murine CD20 monoclonal antibody, which has been administered in treating hematological malignancies and various autoimmune disorders. …”
Get full text
Article -
814
Case Report: long-term misdiagnosis and follow-up of a patient with HNF4A-MODY carrying a new de novo mutation
Published 2025-06-01“…At a routine follow-up at age 21, another physician observed that his pancreatic islet function remained preserved, with negative results for diabetes-related antibodies. …”
Get full text
Article -
815
Immunobiological status of the organism of young pigs during their triphasic period cultivation and actions of corrective factors
Published 2024-05-01“…Research data prove that the specificity of the action of Ig Y has a positive effect on the preservation of the integrity of the villi of the intestinal mucosa, which is reflected by the strengthening of its protective and barrier function, which in general contributes to the increase in the percentage of animal survival: using Globigen®Pig Doser 80.0 % and 86.7 % using Globigen®Jump Start. …”
Get full text
Article -
816
The combination of dietary active dry yeast and Bacillus subtilis improves productive performance, egg quality, and immunity of aged breeder hens
Published 2025-09-01“…This study aimed to investigate the effects of dietary supplementation with active dry yeast (ADY) alone or in combination with Bacillus subtilis (BS) on physiological parameters (laying performance, egg quality, blood indexes), reproductive traits, ileum microbiome, metabolome, and uterine gene expression in aged breeder hens. …”
Get full text
Article -
817
Novel cholinesterase paralogs of Schistosoma mansoni have perceived roles in cholinergic signalling and drug detoxification and are essential for parasite survival.
Published 2019-12-01“…Antibodies to recombinant forms of each SmChE localized the proteins to the tegument of adults and schistosomula and developmental expression profiling differed among the three molecules, suggestive of functions extending beyond traditional cholinergic signaling. …”
Get full text
Article -
818
Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American Co...
Published 2024-03-01“…Maintaining and strengthening the health of the population is one of the primary functions of society. Inadequate understanding of the importance of contraception by the medical community and its application by society can lead to the population’s reproductive health becoming compromised. …”
Get full text
Article -
819
Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19
Published 2023-03-01“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), may lead to thyroid disorders, including both thyrotoxicosis and suppression of thyroid function. The aim of the present study was to assess the post-COVID-19 effects on thyroid function in patients without history of thyroid disease after complete recovery from mild-to-moderate COVID-19. …”
Get full text
Article -
820
NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
Published 2017-03-01“…Special attention is paid to the clinical efficacy and safety of anti-IL-17A monoclonal antibody secukinumab used to treat psoriasis, PsA, AS, and RA.…”
Get full text
Article